OM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Outset Medical's gross profit for the three months ended in Sep. 2024 was $9.8 Mil. Outset Medical's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was $35.5 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Outset Medical's gross profit for the three months ended in Sep. 2024 was $9.8 Mil. Outset Medical's Revenue for the three months ended in Sep. 2024 was $28.7 Mil. Therefore, Outset Medical's Gross Margin % for the quarter that ended in Sep. 2024 was 34.26%.
Outset Medical had a gross margin of 34.26% for the quarter that ended in Sep. 2024 => Competition eroding margins
During the past 6 years, the highest Gross Margin % of Outset Medical was 30.97%. The lowest was -304.68%. And the median was -9.35%.
The historical data trend for Outset Medical's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Outset Medical Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Gross Profit | Get a 7-Day Free Trial | -17.80 | -13.04 | 7.61 | 17.83 | 29.00 |
Outset Medical Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Gross Profit | Get a 7-Day Free Trial | 7.16 | 7.71 | 8.22 | 9.78 | 9.82 |
For the Medical Devices subindustry, Outset Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Outset Medical's Gross Profit distribution charts can be found below:
* The bar in red indicates where Outset Medical's Gross Profit falls into.
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Outset Medical's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as
Gross Profit (A: Dec. 2023 ) | = | Revenue | - | Cost of Goods Sold |
= | 130.376 | - | 101.376 | |
= | 29.0 |
Outset Medical's Gross Profit for the quarter that ended in Sep. 2024 is calculated as
Gross Profit (Q: Sep. 2024 ) | = | Revenue | - | Cost of Goods Sold |
= | 28.666 | - | 18.846 | |
= | 9.8 |
Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.5 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
Outset Medical's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as
Gross Margin % (Q: Sep. 2024 ) | = | Gross Profit (Q: Sep. 2024 ) | / | Revenue (Q: Sep. 2024 ) |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | 9.8 | / | 28.666 | |
= | 34.26 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Outset Medical (NAS:OM) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Outset Medical had a gross margin of 34.26% for the quarter that ended in Sep. 2024 => Competition eroding margins
Thank you for viewing the detailed overview of Outset Medical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Leslie Trigg | director, officer: President & CEO | C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112 |
Marc Nash | officer: SVP, Operations and R&D | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Nabeel Ahmed | officer: Interim CFO | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
John L. Brottem | officer: General Counsel | 3052 ORCHARD DR., SAN JOSE CA 95134 |
D Keith Grossman | director | |
Jean-olivier Racine | officer: Chief Technology Officer | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Steven S. Williamson | officer: Chief Commercial Officer | C/O HOLOGIC, INC., BEDFORD MA 01730 |
Stacey L. Porter | officer: Chief People Officer | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Martin Vazquez | officer: Chief Operating Officer | 3052 ORCHARD DR., SAN JOSE CA 95134 |
James F. Hinrichs | director | 3750 TORREY VIEW COURT, SAN DIEGO CA 92130 |
Dale E Jones | director | C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801 |
Rebecca Chambers | officer: Chief Financial Officer | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Catherine M. Szyman | director | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Warburg Pincus Llc | director, 10 percent owner | 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Warburg Pincus X, L.p. | director, 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
From GuruFocus
By Marketwired • 10-24-2024
By Marketwired • 10-23-2024
By Marketwired • 10-23-2024
By Business Wire • 10-18-2024
By Marketwired • 10-23-2024
By GuruFocus News • 11-07-2024
By Marketwired • 10-23-2024
By PRNewswire • 10-18-2024
By Marketwired • 11-15-2024
By Marketwired • 11-06-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.